Skip to main content
. Author manuscript; available in PMC: 2022 Oct 5.
Published in final edited form as: Cell Rep. 2022 Sep 20;40(12):111400. doi: 10.1016/j.celrep.2022.111400

Table 1.

Clinical characteristics of adult subjects

Non-failing controls
 DCM
EA AA EA
Total subjects 18 8 18
Gender: Male/Female 10/8 6/2 10/8
Age at surgery (years) 50 ± 10 49 ± 13 54 ± 8
BMI (kg/m2) 29 ± 7 26 ± 4 27 ± 6
Prior hypertension (%) 33 37.5 28
Prior diabetes (%) 5.5 14† 11
LVEF (%) 63 ± 6 54 ± 8† 14 ± 3*
Heart mass (g) 373 ± 74 424 ± 82 525 ± 95*

Quantitative data provided as mean ± standard deviation.

*

p < 0.05 significantly different between EA DCM and EA non-failing cohorts by two-tailed t test.

†

Data unavailable for some subjects.

AA, African American; BMI, body mass index; EA, European American; LVEF, left ventricular ejection fraction. For additional clinical information about subjects see Table S1.